A review on targeted therapies for lung cancer

A review on targeted therapies for lung cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Библиографические подробности
Главный автор:	Ashraf, Anushey
Другие авторы:	Khan, Tanisha Tabassum Sayka
Формат:	Диссертация
Язык:	English
Опубликовано:	Brac University 2023
Предметы:	Lung cancer Antibodies Targeted therapy Vaccines Lung cancer > Treatment
Online-ссылка:	http://hdl.handle.net/10361/19353

Схожие документы

Immunotherapy in the Management of Lung Cancer
по: Tasnim, Humayra
Опубликовано: (2022)

Potential of liposomes for the treatment of lung cancer- a review
по: Mim, Shanzida
Опубликовано: (2023)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
по: Tania, Umme
Опубликовано: (2023)

Molecules associated with the development of lung cancer
по: Rahman, Adree, и др.
Опубликовано: (2023)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
по: Paul, Pulock
Опубликовано: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
по: Rahman, Tasnim
Опубликовано: (2024)

A review on recent advances in drugs for lung cancer treatment
по: Noor, Fouzia
Опубликовано: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
по: Jeba, Joynob
Опубликовано: (2017)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
по: Razna, Amrin Islam
Опубликовано: (2019)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
по: Flora, Sanzida Alam
Опубликовано: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
по: Pial, Sazia Afrin
Опубликовано: (2018)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
по: Zangmo, Thinley
Опубликовано: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
по: Hoque, Ismoth Ara
Опубликовано: (2024)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
по: Shabnam, Musharrat
Опубликовано: (2018)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
по: Bristy, Israt Zerin
Опубликовано: (2021)

Targeted therapeutic options in the treatment of Breast Cancer
по: Alam, Kazi Tasnuva
Опубликовано: (2022)

Lung cancer detection and classification using machine learning
по: Arefin, Mahbubul, и др.
Опубликовано: (2023)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
по: Das, Reshita
Опубликовано: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
по: Jahan, Nusrat
Опубликовано: (2024)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
по: Nandy, Aditi
Опубликовано: (2022)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
по: Mukti, Roushney Fatima, и др.
Опубликовано: (2016)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
по: Kamal, Tasnova
Опубликовано: (2019)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
по: Nahar, Kamrun
Опубликовано: (2023)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
по: Ratu, Tabassum
Опубликовано: (2024)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
по: Parvez, Safi
Опубликовано: (2023)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
по: Meem, Manila
Опубликовано: (2023)

A comprehensive review on drug repurposing in cancer treatment
по: Sarkar, Onusree
Опубликовано: (2024)

The impact of cell penetrating peptides in prospective cancer therapy: a review
по: Nashrah, Zannatul
Опубликовано: (2023)

Breast cancer therapy through Liposomal drug delivery system
по: Ome, Nusrat Jahan
Опубликовано: (2024)

Trend in approval of targeted biologics in the last two decades
по: Siddika, Khadiza
Опубликовано: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
по: Hasan, Amit
Опубликовано: (2024)

Current practice and approaches of immunotherapy in Cancer treatment
по: Khondokar, Faiza
Опубликовано: (2022)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
по: Karim, Samia Binte
Опубликовано: (2024)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
по: Alam, Tahera
Опубликовано: (2024)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
по: Abir, Shifaty Nur
Опубликовано: (2024)

A review paper on Nanotechnology based strategies in the treatment of cancer
по: Rahman, Samia
Опубликовано: (2022)

A review on potential of PARP inhibitors in the treatment of prostate cancer
по: Islam, Saidul
Опубликовано: (2022)

The uses of bacteria in cancer therapy
по: Saha, Shimul, и др.
Опубликовано: (2021)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
по: Chakraborty, Anuradha
Опубликовано: (2024)

Concepts and challenges of biosimilars to mitigate the oncology drug expenses
по: Tania, Umme
Опубликовано: (2021)